user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Mar 13, 2023open-state

Tracts, Pathways, and Systems in Anatomical and Clinical Orientation | Neuroanatomy Atlas in Clinical Context: Structures, Sections, Systems, and Syndromes, 10e | Medical Education | Health Library

ipsilateral

posterior column (PC)

lateral medulla

-

Tracts, Pathways, and Systems in Anatomical and Clinical Orientation | Neuroanatomy Atlas in Clinical Context: Structures, Sections, Systems, and Syndromes, 10e | Medical Education | Health Librarymeded.lwwhealthlibrary.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Jan 20, 2023open-state

There are no games like Old World. (4x Game) - YouTube

snapshot

2:44

-

There are no games like Old World. (4x Game) - YouTubewww.youtube.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Dec 15, 2022open-state

ITV Panto- Cinderella - YouTube

snapshot

12:53

-

ITV Panto- Cinderella - YouTubewww.youtube.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Dec 11, 2022open-state

STAR WARS JEDI FALLEN ORDER Full Movie (2022) 4K ULTRA HD Action Fantasy - YouTube

snapshot

24:51

-

STAR WARS JEDI FALLEN ORDER Full Movie (2022) 4K ULTRA HD Action Fantasy - YouTubewww.youtube.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Aug 3, 2022open-state

Cardiovascular | Cases and Concepts Step 1: Pathophysiology Review | Medical Education | Health Library

The stroke volume is determined by three parameters: (1) contractility, (2) preload, and (3) afterload.

Preload is defined as the ventricular wall tension at the end of diastole and is quantified by the left ventricular end-diastolic pressure (LVEDP).

Afterload is the ventricular wall tension during systole and is determined by the mean arterial pressure.

-

Cardiovascular | Cases and Concepts Step 1: Pathophysiology Review | Medical Education | Health Librarymeded.lwwhealthlibrary.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Jul 22, 2022open-state

Healthy behavioral choices and cancer screening in persons living with HIV/AIDS are different by sex and years since HIV diagnosis - PMC

In the analysis of age-appropriate screening among males, 64.8% never had an anal Pap-smear, 36.2% never had a colonoscopy, and 38.9% never had prostate cancer screening. In the analysis of age-appropriate screening among females, 50.0% never had an anal Pap-smear, 46.5% never had a colonoscopy, 7.9% never had a cervical Pap-smear and 12.7% never had a mammogram.

Additionally, for each participant in the Florida Cohort, medical history (such as HIV viral load, CD4 T-cell count, height and weight) was collected through electronic medical record abstraction and linkage to the Enhanced HIV/AIDS Reporting System (eHARS) database which is a real time medical information collection application provided by the Centers for Disease Control and Prevention [27].

Overall, 36.3% of the participants were obese, 9.0% were non-compliant to recommended alcohol intake limits, 50.7% were current smokers and 12.4% reported never engaging in physical activity that was long enough to work up a sweat.

-

Healthy behavioral choices and cancer screening in persons living with HIV/AIDS are different by sex and years since HIV diagnosis - PMCwww.ncbi.nlm.nih.gov

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Jul 11, 2022open-state

Inclusion and diversity in clinical trials: Actionable steps to drive lasting change - ScienceDirect

Improving diversity in clinical trials is essential in order to produce generalizable results.

Although much work has been done in this area, we have not yet realized the potential gains of initiatives to enhance diversity and inclusivity in clinical trials in the United States (U.S.). Among 32,000 individuals who participated in new drug trials in the U.S. in 2020, only 8% were Black, 6% Asian, 11% Hispanic, and 30% were age 65 and older, showing relative underrepresentation of these important demographic groups [1].

In contrast to these low trial participation statistics, underrepresented racial and ethnic minority groups carry a disproportionately high burden of chronic diseases that garner the most investment in drug research and development [3].

-

Inclusion and diversity in clinical trials: Actionable steps to drive lasting change - ScienceDirectwww.sciencedirect.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Jul 11, 2022open-state

Racial/Ethnic Disparities in Chronic Diseases of Youths and Access to Health Care in the United States

Racial/ethnic minorities are 1.5 to 2.0 times more likely than whites to have most of the major chronic diseases.

The most common major chronic diseases of youth in the United States are asthma, diabetes mellitus, obesity, hypertension, dental disease, attention-deficit/hyperactivity disorder, mental illness, cancers, sickle-cell anemia, cystic fibrosis, and a variety of genetic and other birth defects

However, the general rule of thumb is that chronic diseases in childhood are more common in boys, older youths, those from low-income families, and racial/ethnic minorities.

-

Racial/Ethnic Disparities in Chronic Diseases of Youths and Access to Health Care in the United Stateswww.hindawi.com

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Jul 7, 2022open-state

The Florida Cohort Study: Methodology, initial findings and lessons learned from a multisite cohort of people living with HIV in Florida - PMC

The mean age of study participants was 46.7±11.2 years, 64% were male, and the racial/ethnic distribution was 55% black, 20% Latinx, and 21% white.

Approximately one-third (34%) had less than a high-school education, most reported currently drinking (71%) and almost a third reporting hazardous drinking (35%); however, only 9% reported heavy drinking.

Florida Cohort participants were enrolled from clinics and community-based organizations in eight geographically diverse counties across Florida.

-

The Florida Cohort Study: Methodology, initial findings and lessons learned from a multisite cohort of people living with HIV in Florida - PMCwww.ncbi.nlm.nih.gov

user-profile-img

Danny Guillen

@dnguillen37qkpt2_osj_• Jul 7, 2022open-state

Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study - ScienceDirect

Additional efforts aimed at cancer prevention and screening in people with HIV are warranted.

However, treatment might not fully reverse the effect of early immune suppression, and immune dysfunction and chronic inflammation can persist among people receiving ART.

Finally, with prolonged survival the HIV population is ageing, and the effect of HIV-related immunosuppression in an ageing population is unclear.10, 14 For these reasons, continued monitoring of cancer risks in this population is vital.

-

Cancer risk in HIV-infected people in the USA from 1996 to 2012: a population-based, registry-linkage study - ScienceDirectwww.sciencedirect.com